Physician profile
Aaron Rubenstein
NPI 1194363234
$5,048.59
in general payments reported to CMS, 2019-2025
29 companies · $3,038 in 2025
The $3,038 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $413 · 2024: $1,598 · 2025: $3,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,926 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,925.70 |
| Education | $122.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,081.60 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $707.11 | 2023-2025 | Fasenra, Airsupra, Breztri |
| Regeneron Healthcare Solutions, INC. | $404.76 | 2023-2025 | Dupixent |
| Genzyme Corporation | $347.44 | 2023-2025 | |
| Verona Pharma, INC. | $324.98 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $318.27 | 2023-2025 | Aralast |
| Jazz Pharmaceuticals INC. | $270.20 | 2023-2025 | |
| Harmony Biosciences LLC | $263.54 | 2023-2025 | Wakix |
| Amgen INC. | $222.04 | 2023-2025 | Tezspire |
| Insmed, INC. | $164.76 | 2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $154.95 | 2023-2025 | Opsumit, Uptravi |
| United Therapeutics Corporation | $102.84 | 2024-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $102.42 | 2023-2025 | Hillrom - Life 2000 Ventilation System |
| Ani Pharmaceuticals, INC. | $78.49 | 2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $68.28 | 2023-2024 | Xolair |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $58.97 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Axsome Therapeutics, INC. | $51.76 | 2025 | Sunosi |
| Electromed, INC. | $51.60 | 2023-2025 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $51.02 | 2024-2025 | Lumryz |
| Bayer Healthcare Pharmaceuticals INC. | $34.00 | 2024 | |
| Mylan Specialty L.P. | $31.98 | 2024 | Yupelri |
| Lilly USA, LLC | $30.41 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $22.92 | 2024 | Inspire |
| Grifols USA, LLC | $22.91 | 2025 | Prolastin-C Liquid |
| Abbvie INC. | $18.38 | 2025 | |
| Merck Sharp & Dohme LLC | $16.91 | 2023 | Belsomra |
| Vifor Pharma, INC. | $16.48 | 2025 | Veltassa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.93 | 2024 | Spiriva Respimat, Stiolto Respimat |
| Genmab U.S., INC. | $13.64 | 2024 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.